0

Bromocriptine and premenstrual symptoms: a survey of double blind trials

Andersch B, 1983

Obstetrical & gynecological survey, 38(11), 643-646

DOI 10.1097/00006254-198311000-00001 PMID 6358978 Source

Abstract

This is a survey of 14 placebo-controlled studies regarding the treatment of premenstrual symptoms with bromocriptine. There is no substantial support that bromocriptine is an effective drug in the premenstrual syndrome as an entity. Symptoms such as irritability, depression, and anxiety were not significantly improved during treatment with bromocriptine compared to placebo treatment. Bromocriptine appears to be the treatment of choice in premenstrual mastodynia if the dosage of bromocriptine is at least 5 mg daily. Bromocriptine may therefore have a place in selected cases of the premenstrual syndrome with associated mastodynia.

Topics

Menstrual Cycle > Disorders > PMDDReproductive Endocrinology > Prolactin > TreatmentGeneral OB/GYN > Clinical Practice > Guidelines
bromocriptine premenstrual syndrome treatment, bromocriptine pms symptoms review, premenstrual mastodynia treatment options, dopamine agonist premenstrual symptoms, bromocriptine breast pain pms, premenstrual syndrome pharmaceutical treatment, bromocriptine versus placebo pms, cyclical breast pain bromocriptine, premenstrual symptom management medications

Cite this article

Andersch, B. (1983). Bromocriptine and premenstrual symptoms: a survey of double blind trials. *Obstetrical & gynecological survey*, *38*(11), 643-646. https://doi.org/10.1097/00006254-198311000-00001

Keywords

Adult, Bromocriptine, Clinical Trials As Topic, Double-Blind Method, Female, Humans, Premenstrual Syndrome

Related articles